{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:40:46Z","timestamp":1790044846948,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK034987"],"award-info":[{"award-number":["DK034987"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11136-026-04364-z","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:38:05Z","timestamp":1787233085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and evaluation of PROMIS\u00ae fatigue and cognitive function short forms customized for adults with primary sclerosing cholangitis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-1846","authenticated-orcid":false,"given":"Donna M.","family":"Evon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mkumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-4922","authenticated-orcid":false,"given":"Nicole","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5111-4568","authenticated-orcid":false,"given":"Rachel Ciaves","family":"Gomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-6811","authenticated-orcid":false,"given":"Ricky","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kallie","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-8714","authenticated-orcid":false,"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"2","key":"4364_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus, C. L., Arriv\u00e9, L., Bergquist, A., et al. (2023). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 77(2), 659\u2013702.","journal-title":"Hepatology"},{"issue":"1","key":"4364_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1055\/s-0038-1676099","volume":"39","author":"V Ranieri","year":"2019","unstructured":"Ranieri, V., McKay, K., Walmsley, M., Senior, R., Thorburn, D., & Kennedy, E. (2019). Primary sclerosing cholangitis and psychological wellbeing: A scoping review. Seminars In Liver Disease, 39(1), 104\u2013110.","journal-title":"Seminars In Liver Disease"},{"issue":"7","key":"4364_CR3","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.cgh.2018.04.047","volume":"17","author":"A Kuo","year":"2019","unstructured":"Kuo, A., Gomel, R., Safer, R., Lindor, K. D., Everson, G. T., & Bowlus, C. L. (2019). Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry. Clinical Gastroenterology And Hepatology, 17(7), 1372\u20131378.","journal-title":"Clinical Gastroenterology And Hepatology"},{"issue":"7","key":"4364_CR4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/liv.15271","volume":"42","author":"KN van Munster","year":"2022","unstructured":"van Munster, K. N., Dijkgraaf, M. G. W., Oude Elferink, R. P. J., Beuers, U., & Ponsioen, C. Y. (2022). Symptom patterns in the daily life of PSC patients. Liver International : Official Journal Of The International Association For The Study Of The Liver, 42(7), 1562\u20131570.","journal-title":"Liver International : Official Journal Of The International Association For The Study Of The Liver"},{"issue":"1","key":"4364_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/hep.29664","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi, Z. M., Afendy, A., Stepanova, M., Racila, A., Nader, F., Gomel, R., Safer, R., Lenderking, W. R., Skalicky, A., Kleinman, L., Myers, R. P., Subramanian, G. M., McHutchison, J. G., Levy, C., Bowlus, C. L., Kowdley, K., & Muir, A. J. (2018). Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO. Hepatology, 68(1), 155\u2013165. . Epub 2018 May 10. PMID: 29152767. https:\/\/doi.org\/10.1002\/hep.29664","journal-title":"Hepatology"},{"key":"4364_CR6","unstructured":"PSC Partners Seeking a Cure. The Voice of the Patient: Primary Sclerosing Cholangitis (PSC): Report of an Externally-Led Patient-Focused Drug Development Meeting [Internet]. PSC-Partners Patient-Focused Drug Development Forum (PFDD) (2022). [cited 2025 Sep 6]. https:\/\/pscpartners.org\/resources\/patient-focused-drug-development.html"},{"key":"4364_CR7","doi-asserted-by":"crossref","unstructured":"Li, M., Pai, R-A., Gomel, R. (2024). Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials. Hepatol Commun ;8(6).","DOI":"10.1097\/HC9.0000000000000433"},{"key":"4364_CR8","doi-asserted-by":"crossref","unstructured":"Evon DM, Merkler K, Anderson C, Deutsch-Link S, Gomel R, Hatchett J, Safer R, Rossi SJ, Bowlus CL, Swain M, Reeve BB. (2026). Symptom burden is associated with health-related quality of life in symptomatic adults with primary sclerosing cholangitis. Accepted Hepatol Commun .","DOI":"10.1097\/HC9.0000000000001009"},{"issue":"3","key":"4364_CR9","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.29882","volume":"68","author":"CY Ponsioen","year":"2018","unstructured":"Ponsioen, C. Y., Lindor, K. D., Mehta, R., & Dimick-Santos, L. (2018). Design and endpoints for clinical trials in primary sclerosing cholangitis. Hepatology, 68(3), 1174\u20131188.","journal-title":"Hepatology"},{"key":"4364_CR10","unstructured":"U.S. Food & Drug Adminstration FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient\u2019s Voice in Medical Product Development and Regulatory Decision Making | FDA [Internet]. 2024 [cited 2024 Oct 25]. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical"},{"issue":"2","key":"4364_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOG.0000000000001075","volume":"41","author":"DM Evon","year":"2025","unstructured":"Evon, D. M., & Reeve, B. B. (2025). Assessing patient-reported outcomes in primary sclerosing cholangitis: an update. Current Opinion In Gastroenterology, 41(2), 59\u201366. PMID: 39819655.","journal-title":"Current Opinion In Gastroenterology"},{"issue":"10","key":"4364_CR12","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/hep4.1567","volume":"4","author":"HP Kim","year":"2020","unstructured":"Kim, H. P., Lieber, S. R., Rogers, M. E., et al. (2020). A systematic review of patient-reported outcomes in primary biliary cholangitis and primary sclerosing cholangitis. Hepatol Commun, 4(10), 1502\u20131515.","journal-title":"Hepatol Commun"},{"issue":"1","key":"4364_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12955-018-0951-6","volume":"16","author":"F Isa","year":"2018","unstructured":"Isa, F., Turner, G. M., Kaur, G., et al. (2018). Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review. Health And Quality Of Life Outcomes, 16(1), 133.","journal-title":"Health And Quality Of Life Outcomes"},{"key":"4364_CR14","doi-asserted-by":"publisher","unstructured":"Evon,D. M., Merkler, K., Mkumba, L., et al. (2026). Fatigue and Cognitive Impairment in Adults With Primary Sclerosing Cholangitis: Results From Concept Elicitation Interviews. Liver International 46 no, 9. https:\/\/doi.org\/10.1111\/liv.70814","DOI":"10.1111\/liv.70814"},{"issue":"5 Suppl 1","key":"4364_CR15","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/01.mlr.0000250483.85507.04","volume":"45","author":"BB Reeve","year":"2007","unstructured":"Reeve, B. B., Hays, R. D., Bjorner, J. B., et al. (2007). Psychometric evaluation and calibration of health-related quality of life item banks: Plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Medical Care, 45(5 Suppl 1), S22\u201331.","journal-title":"Medical Care"},{"issue":"11","key":"4364_CR16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella, D., Riley, W., Stone, A., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. Journal Of Clinical Epidemiology, 63(11), 1179\u20131194.","journal-title":"Journal Of Clinical Epidemiology"},{"issue":"3","key":"4364_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00012272-199703000-00003","volume":"19","author":"ER Lenz","year":"1997","unstructured":"Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: an update. Ans. Advances In Nursing Science, 19(3), 14\u201327.","journal-title":"Ans. Advances In Nursing Science"},{"key":"4364_CR18","unstructured":"Willis, G. B. (2004). Cognitive interviewing: A tool for improving questionnaire design (1st ed.). Sage."},{"issue":"6","key":"4364_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/104973230201200611","volume":"12","author":"JB Averill","year":"2002","unstructured":"Averill, J. B. (2002). Matrix analysis as a complementary analytic strategy in qualitative inquiry. Qualitative Health Research, 12(6), 855\u2013866.","journal-title":"Qualitative Health Research"},{"issue":"Suppl 1","key":"4364_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11136-007-9198-0","volume":"16","author":"MO Edelen","year":"2007","unstructured":"Edelen, M. O., & Reeve, B. B. (2007). Applying item response theory (IRT) modeling to questionnaire development, evaluation, and refinement. Quality Of Life Research, 16(Suppl 1), 5\u201318.","journal-title":"Quality Of Life Research"},{"issue":"2","key":"4364_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1586\/14737167.3.2.131","volume":"3","author":"BB Reeve","year":"2003","unstructured":"Reeve, B. B. (2003). Item response theory modeling in health outcomes measurement. Expert Rev Pharmacoecon Outcomes Res, 3(2), 131\u2013145.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4364_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jclinepi.2015.08.037","volume":"73","author":"D Cella","year":"2016","unstructured":"Cella, D., Lai, J-S., Jensen, S. E., et al. (2016). PROMIS fatigue item bank had clinical validity across diverse chronic conditions. Journal Of Clinical Epidemiology, 73, 128\u2013134.","journal-title":"Journal Of Clinical Epidemiology"},{"issue":"5","key":"4364_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1037\/hea0000693","volume":"38","author":"TR Valentine","year":"2019","unstructured":"Valentine, T. R., Weiss, D. M., Jones, J. A., & Andersen, B. L. (2019). Construct validity of PROMIS\u00ae Cognitive Function in cancer patients and noncancer controls. Health Psychology, 38(5), 351\u2013358.","journal-title":"Health Psychology"},{"issue":"7","key":"4364_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/arclin\/acaa128","volume":"36","author":"GL Iverson","year":"2021","unstructured":"Iverson, G. L., Marsh, J. M., Connors, E. J., & Terry, D. P. (2021). Normative reference values, reliability, and item-level symptom endorsement for the PROMIS\u00ae v2.0 cognitive function-short forms 4a, 6a and 8a. Archives Of Clinical Neuropsychology : The Official Journal Of The National Academy Of Neuropsychologists, 36(7), 1341\u20131349.","journal-title":"Archives Of Clinical Neuropsychology : The Official Journal Of The National Academy Of Neuropsychologists"},{"key":"4364_CR25","unstructured":"Willis, G. B. (2015). Analysis of The Cognitive Interview in Questionnaire Design. University."},{"issue":"8","key":"4364_CR26","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jval.2025.05.002","volume":"28","author":"M Krol","year":"2025","unstructured":"Krol, M., Maher, J., Halmos, T., et al. (2025). The increasing use of clinical outcome assessments in US food and drug administration labels and the german gemeinsamer bundesausschuss, national institute for health and care excellence, and the french haute autorit\u00e9 de sant\u00e9 assessments from 2012 to 2022. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 28(8), 1195\u20131203.","journal-title":"Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research"},{"issue":"4","key":"4364_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/10547738211014099","volume":"30","author":"K Meadows","year":"2021","unstructured":"Meadows, K. (2021). Cognitive Interviewing Methodologies. Clinical Nursing Research, 30(4), 375\u2013379.","journal-title":"Clinical Nursing Research"},{"key":"4364_CR28","unstructured":"US Food & Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research Center for Devices and Radiological Health. Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments [Internet]. GUIDANCE DOCUMENT Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments October 2025. 2025 [cited 2026 Jul 7]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-selecting-developing-or-modifying-fit-purpose-clinical-outcome"},{"issue":"1","key":"4364_CR29","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.aohep.2025.101901","volume":"30","author":"M Wang","year":"2025","unstructured":"Wang, M., Harris, A., McCulloch, C. E., Wadhwani, S. I., Lai, J. C., & Rubin, J. B. (2025). Racial differences in primary sclerosing cholangitis: A retrospective cohort study leveraging a new ICD-10 code. Annals Of Hepatology, 30(1), 101901.","journal-title":"Annals Of Hepatology"},{"issue":"4","key":"4364_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cgh.2017.10.028","volume":"16","author":"DS Goldberg","year":"2018","unstructured":"Goldberg, D. S., Levy, C., Yimam, K., et al. (2018). Primary sclerosing cholangitis is not rare among blacks in a multicenter north american consortium. Clinical Gastroenterology And Hepatology, 16(4), 591\u2013593.","journal-title":"Clinical Gastroenterology And Hepatology"},{"issue":"1","key":"4364_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","volume":"80","author":"KN van Munster","year":"2024","unstructured":"van Munster, K. N., Bergquist, A., & Ponsioen, C. Y. (2024). Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two? Journal Of Hepatology, 80(1), 155\u2013168.","journal-title":"Journal Of Hepatology"},{"key":"4364_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-230X-11-83","volume":"11","author":"E Toy","year":"2011","unstructured":"Toy, E., Balasubramanian, S., Selmi, C., Li, C-S., & Bowlus, C. L. (2011). The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. Bmc Gastroenterology, 11, 83.","journal-title":"Bmc Gastroenterology"},{"issue":"8","key":"4364_CR33","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/liv.15339","volume":"42","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Gao, X., He, Z., et al. (2022). Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis. Liver International : Official Journal Of The International Association For The Study Of The Liver, 42(8), 1814\u20131822.","journal-title":"Liver International : Official Journal Of The International Association For The Study Of The Liver"},{"issue":"1","key":"4364_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41687-019-0105-6","volume":"3","author":"CO Bingham Iii","year":"2019","unstructured":"Bingham Iii, C. O., Gutierrez, A. K., Butanis, A., et al. (2019). PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. J Patient Rep Outcomes, 3(1), 14.","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"4364_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41687-023-00575-x","volume":"7","author":"A Findley","year":"2023","unstructured":"Findley, A., Middlehurst, J. M., Howse, C. A., et al. (2023). Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS\u00ae Short Forms: A study in patients with axial spondyloarthritis. J Patient Rep Outcomes, 7(1), 39.","journal-title":"J Patient Rep Outcomes"},{"issue":"6","key":"4364_CR36","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11136-011-0011-8","volume":"21","author":"KF Cook","year":"2012","unstructured":"Cook, K. F., Bamer, A. M., Roddey, T. S., Kraft, G. H., Kim, J., & Amtmann, D. (2012). A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Quality Of Life Research, 21(6), 1021\u20131030.","journal-title":"Quality Of Life Research"},{"issue":"9","key":"4364_CR37","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1007\/s00520-018-4614-2","volume":"27","author":"KA Dickinson","year":"2019","unstructured":"Dickinson, K. A., Kelly, D. L., Lai, J-S., & Saligan, L. N. (2019). Development of the PROMIS-based Research Assessment and Clinical Tool-Fatigue (ReACT-F). Supportive Care In Cancer, 27(9), 3375\u20133383.","journal-title":"Supportive Care In Cancer"},{"key":"4364_CR38","unstructured":"PSC Partners Seeking a Cure Primary sclerosing cholangitis patient registry [Internet]. PSC Partners primary sclerosing cholangitis patient registry. [cited 2026 Mar 24]. https:\/\/www.pscpartnersregistry.org\/"},{"key":"4364_CR39","unstructured":"HealthMeasures [Internet] Healthmeasures. [cited 2026 Jun 4]. https:\/\/www.healthmeasures.net\/"},{"key":"4364_CR40","unstructured":"HealthMeasures Scoring Service powered by Assessment CenterSM [Internet] HealthMeasures Scoring Service powered by Assessment CenterSM. [cited 2026 Jun 4]. https:\/\/www.assessmentcenter.net\/ac_scoringservice"},{"issue":"3","key":"4364_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/ecco-jcc\/jjv218","volume":"10","author":"D Farrell","year":"2016","unstructured":"Farrell, D., McCarthy, G., & Savage, E. (2016). Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis, 10(3), 315\u2013322.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"4364_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.psym.2020.10.002","volume":"62","author":"CWP Hopkins","year":"2021","unstructured":"Hopkins, C. W. P., Powell, N., Norton, C., Dumbrill, J. L., Hayee, B., & Moulton, C. D. (2021). Cognitive impairment in adult inflammatory bowel disease: A systematic review and meta-analysis. Journal of the Academy of Consultation-Liaison Psychiatry, 62(4), 387\u2013403.","journal-title":"Journal of the Academy of Consultation-Liaison Psychiatry"},{"issue":"2","key":"4364_CR43","doi-asserted-by":"publisher","first-page":"e0049","DOI":"10.1097\/HC9.0000000000000049","volume":"7","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M., Stepanova, M., Younossi, I., & Racila, A. (2023). Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC. Hepatol Commun, 7(2), e0049.","journal-title":"Hepatol Commun"},{"issue":"5","key":"4364_CR44","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/liv.15542","volume":"43","author":"B Mol","year":"2023","unstructured":"Mol, B., van Munster, K. N., Bogaards, J. A., et al. (2023). Health-related quality of life in patients with primary sclerosing cholangitis: A longitudinal population-based cohort study. Liver International : Official Journal Of The International Association For The Study Of The Liver, 43(5), 1056\u20131067.","journal-title":"Liver International : Official Journal Of The International Association For The Study Of The Liver"},{"issue":"8","key":"4364_CR45","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1111\/liv.15650","volume":"43","author":"M Walmsley","year":"2023","unstructured":"Walmsley, M., Tornai, D., Cazzagon, N., et al. (2023). Patient-reported quality of care in primary sclerosing cholangitis. Liver International : Official Journal Of The International Association For The Study Of The Liver, 43(8), 1654\u20131662.","journal-title":"Liver International : Official Journal Of The International Association For The Study Of The Liver"},{"issue":"2","key":"4364_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild, D., Grove, A., Martin, M., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 8(2), 94\u2013104.","journal-title":"Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04364-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:36Z","timestamp":1789643136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04364-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4364"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04364-z","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Christopher L. Bowlus\n                      : Advisory role: Gilead, Ipsen, Intercept, GSK, Mirum, Cymabay, COUR, Kezar, Astra Zeneca, Esperion, Pliant, Chemomab; Grants: BMS, Chemomab, COUR, Cymabay, Gilead, GSK, Hanmi, Intercept, Ipsen, Mirum, Novartis, Novo Nordisk, Pliant, Viking, Zydus.\n                      Bryce Reeve\n                      : Consultant \u2013 Daiichi Sankyo, Vertex Pharmaceuticals. Other authors have nothing to disclose.","order":1,"name":"Ethics","label":"<b>Conflict of interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the University of North Carolina at Chapel Hill Institutional Review Board (IRB# 22-2477). All participants provided verbal consent using an IRB-approved protocol and script.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained and tracked from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"263"}}